Researcher on 340B: Physicians 'select patients who require more intensive pharmaceutical treatments after joining the 340B program'
Danea Horn, a researcher at the University of California, has indicated that physicians or their employer organizations might select patients requiring intensive pharmaceutical treatments to benefit from financial incentives under the 340B program. Read More »